Julie A. Vetalice, Author at ORTHOWORLD

OrthoMend Acquires License to Absorbable Bone Fixation, Repair Technologies

Competitive Landscape Mergers & Acquisitions

OrthoMend Research acquired from Temple University researchers an exclusive license to develop novel absorbable bone fixation and regenerative repair technologies for commercial use.

Dec 09, 2016

Three-Month Interim Safety Data from Phase I Clinical Trial of AlloJoin

Orthobiologics ORTHOFLASH

Three-month safety data from a Phase I clinical trial in China for Cellular Biomedicine’s AlloJoin™ off-the-shelf allogeneic stem cell therapy in the treatment of knee osteoarthritis demonstrated a safety and tolerability profile of AlloJoin in the three doses tested, with adverse events similar to that of earlier autologous trials. The trial is slated for completion in 3Q17.

Dec 09, 2016

Strategic orthopaedic-related 510(k)s issued in November 2016

Company Updates Competitive Landscape

Strategic orthopaedic-related 510(k)s issued in November 2016 include: Preference Elite Pedicle Screw System (Amedica); Titanium Porous Fixation Device (Amorchem); Moss 100 Pedicle Screw System (Biedermann Motech); Persona Partial Knee (Biomet/Zimmer Biomet); AltiVate Anatomic Shoulder, Exprt Revision Hip (Encore Medical/DJO); Initia Total Hip & Bioceram AZUL Head (Kyocera Medical); Virtu C Spinal Implant (Met 1); Interference Screw (Nanova Biomaterials); Fortezza Spinal Stabilization System (Osso Surgical)

Dec 09, 2016

Study Results: Biomatlante’s MBCP+ Synthetic Bone Graft and MSCs

Orthobiologics ORTHOFLASH

Study results demonstrated a high rate of clinical success from a combination of Biomatlante’s MBCP+™ synthetic bone graft plus mesenchymal stem cells, particularly in the treatment of long bone non-union fractures.

Dec 09, 2016

curasan Receives FDA Clearance for CERASORB Ortho FOAM

Orthobiologics ORTHOFLASH

curasan received FDA 510(k) clearance to market CERASORB Ortho FOAM synthetic bone material for the treatment of bone defects in the extremities and pelvis.

Dec 08, 2016

New Indication for RTI Surgical’s C-Plus Peek IBF System

Orthobiologics ORTHOFLASH

RTI Surgical’s C-Plus™ PEEK Interbody Fusion system is now indicated for use with allograft, including the company’s map3® cellular allogeneic bone graft.

Dec 08, 2016

Bodycad Awarded U.S. Patents

ORTHOFLASH Robotics/Tech

Bodycad was awarded two U.S. patents for improving the accuracy, reproducibility and speed for 3D constructs via MRI and CD images in long and small bone orthopaedic applications.

Dec 08, 2016

JRI Orthopaedics Gains Regulatory Approval in China

Joint Replacement ORTHOFLASH

JRI Orthopaedics received regulatory approval in China and will supply 10,000 hips for distribution by AK Medical over a five-year term in a deal valued at minimum £5MM (~US $6.3MM).

Dec 08, 2016

Abyrx Closes $10MM Financing

Investments The Numbers

Abyrx completed a US $10MM equity financing. Funds will support commercialization of bone putty products and pipeline development activities.

Dec 07, 2016

MedPlast Acquired by Strategic Investor, PE Firm

Competitive Landscape Mergers & Acquisitions

MedPlast, parent company of OrthoPlastics, was acquired by strategic investor Water Street Healthcare and JLL Partners, a middle-market private equity firm. Terms were not disclosed.

Dec 07, 2016

Get the ORTHOWORLD Newsletter!

Contact Us